| Eculizumab therapy in children with severe hematopoietic stem cell transplantation–associated thrombotic microangiopathy S Jodele, T Fukuda, A Vinks, K Mizuno, BL Laskin, J Goebel, BP Dixon, ... Biology of Blood and Marrow Transplantation 20 (4), 518-525, 2014 | 251 | 2014 |
| Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab S Jodele, CE Dandoy, A Lane, BL Laskin, A Teusink-Cross, KC Myers, ... Blood, The Journal of the American Society of Hematology 135 (13), 1049-1057, 2020 | 171 | 2020 |
| Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation S Jodele, T Fukuda, K Mizuno, AA Vinks, BL Laskin, J Goebel, BP Dixon, ... Biology of blood and marrow transplantation 22 (2), 307-315, 2016 | 149 | 2016 |
| Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin‐induced lactic acidosis K Toyama, A Yonezawa, S Masuda, R Osawa, M Hosokawa, S Fujimoto, ... British journal of pharmacology 166 (3), 1183-1191, 2012 | 98 | 2012 |
| Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients K Toyama, A Yonezawa, M Tsuda, S Masuda, I Yano, T Terada, R Osawa, ... Pharmacogenetics and genomics 20 (2), 135-138, 2010 | 60 | 2010 |
| Obesity and overweight as CAE comorbidities and differential drug response modifiers R Arya, CW Gillespie, A Cnaan, M Devarajan, P Clark, S Shinnar, ... Neurology 86 (17), 1613-1621, 2016 | 21 | 2016 |
| Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT K Mizuno, CE Dandoy, A Teusink-Cross, SM Davies, AA Vinks, S Jodele Blood Advances 6 (5), 1454-1463, 2022 | 14 | 2022 |
| Population pharmacokinetics and optimal sampling strategy for model-based precision dosing of melphalan in patients undergoing hematopoietic stem cell transplantation K Mizuno, M Dong, T Fukuda, S Chandra, PA Mehta, S McConnell, ... Clinical pharmacokinetics 57, 625-636, 2018 | 14 | 2018 |
| Low-dose dasatinib ameliorates hypertrophic cardiomyopathy in Noonan syndrome with multiple lentigines JS Yi, S Perla, Y Huang, K Mizuno, FJ Giordano, AA Vinks, AM Bennett Cardiovascular Drugs and Therapy, 1-16, 2021 | 10 | 2021 |
| A pharmacokinetic and pharmacodynamic study of maraviroc as acute graft-versus-host disease prophylaxis in pediatric allogeneic stem cell transplant recipients with … P Khandelwal, T Fukuda, K Mizuno, A Teusink-Cross, PA Mehta, ... Biology of Blood and Marrow Transplantation 22 (10), 1829-1835, 2016 | 10 | 2016 |
| Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study S Chandra, T Fukuda, K Mizuno, SM Davies, A Teusink-Cross, R Tarin, ... Journal of Antimicrobial Chemotherapy 73 (6), 1651-1658, 2018 | 8 | 2018 |
| Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders S Chandra, K Mizuno, J Zhao, SM Davies, RA Marsh, T Fukuda, ... British Journal of Clinical Pharmacology 88 (1), 115-127, 2022 | 5 | 2022 |
| Paperspray ionization mass spectrometry as a tool for predicting real-time optimized dosing of the chemotherapeutic drug melphalan J Zhao, C Sharat, PA Mehta, K Mizuno, AA Vinks, KDR Setchell The Journal of Applied Laboratory Medicine 6 (3), 625-636, 2021 | 5 | 2021 |
| Pharmacokinetics and pharmacodynamics estimation of eculizumab in a 2-year-old girl with atypical hemolytic uremic syndrome: A case report with 4-year follow-up K Saida, T Fukuda, K Mizuno, M Ogura, K Kamei, S Ito Frontiers in Pediatrics 7, 519, 2019 | 5 | 2019 |
| Adopting Model‐Informed Precision‐Dosing for Eculizumab in Transplant Associated‐Thrombotic Microangiopathy to Gene Therapies S Jodele, K Mizuno, A Sabulski, AA Vinks Clinical Pharmacology & Therapeutics 114 (3), 511-514, 2023 | 3 | 2023 |
| V2 Trial: a phase i study of venetoclax combined with CPX-351 for children, adolescents and young adults with relapsed or refractory acute leukemia L Agresta, MM O'Brien, K Mizuno, R Norris, EH Breese, CL Phillips, ... Blood 134, 3830, 2019 | 3 | 2019 |
| Test Dose Pharmacokinetics to Predict Melphalan Dosing in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT) with Organ Impairment☆ S Chandra, T Fukuda, J Zhao, K Mizuno, A Teusink-Cross, SM Davies, ... Biology of Blood and Marrow Transplantation 23 (3), S228, 2017 | 2 | 2017 |
| Eculizumab treatment improves survival in patients with high-risk hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TMA) S Jodele, B Laskin, T Fukuda, A Vinks, K Mizuno, J Goebel, KC Myers, ... Biology of Blood and Marrow Transplantation 21 (2), S225-S226, 2015 | 2 | 2015 |
| A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA S Jodele, CE Dandoy, P Aguayo-Hiraldo, A Lane, A Teusink-Cross, ... Blood 143 (12), 1112-1123, 2024 | 1 | 2024 |
| Dosing algorithm for complement inhibitor S Jodele, T Fukuda, K Mizuno US Patent 11,840,564, 2023 | 1 | 2023 |
